Xubin Jing

662 total citations
24 papers, 560 citations indexed

About

Xubin Jing is a scholar working on Molecular Biology, Oncology and Hepatology. According to data from OpenAlex, Xubin Jing has authored 24 papers receiving a total of 560 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Hepatology. Recurrent topics in Xubin Jing's work include Metabolism, Diabetes, and Cancer (6 papers), Liver Disease Diagnosis and Treatment (4 papers) and Liver Disease and Transplantation (4 papers). Xubin Jing is often cited by papers focused on Metabolism, Diabetes, and Cancer (6 papers), Liver Disease Diagnosis and Treatment (4 papers) and Liver Disease and Transplantation (4 papers). Xubin Jing collaborates with scholars based in China, Japan and Nepal. Xubin Jing's co-authors include Xianbin Cai, Jidong Cheng, Xiaojun Tan, Xi Hu, Qinjia Wang, Youfeng Li, Toshikazu Hada, Hiroyasu Imanishi, Noboru Ueki and Bozhi Cai and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and BMC Public Health.

In The Last Decade

Xubin Jing

21 papers receiving 548 citations

Peers

Xubin Jing
Comparison fields: 5 of 73
  • Molecular Biology 331
  • Epidemiology 117
  • Oncology 111
  • Cancer Research 100
  • Nephrology 82
Replace Song Ling Poon with:
Song Ling Poon Canada
Zhaolin Sun China
Chengcheng Gao China
Zhipeng Du China
Xudong Hu China
Jian‐Ping Che China
Wenguang Fu China
Yan‐Zi Yang China
Hiroyasu Imanishi Japan
Desen Liang China
Song Ling Poon Canada View profile →
Citations per field, relative to Xubin Jing
Xubin Jing · 1×
Citations per year, relative to Xubin Jing
Xubin Jing · 1×

Countries citing papers authored by Xubin Jing

Since Specialization
Citations

This map shows the geographic impact of Xubin Jing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xubin Jing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xubin Jing more than expected).

Fields of papers citing papers by Xubin Jing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xubin Jing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xubin Jing. The network helps show where Xubin Jing may publish in the future.

Co-authorship network of co-authors of Xubin Jing

This figure shows the co-authorship network connecting the top 25 collaborators of Xubin Jing. A scholar is included among the top collaborators of Xubin Jing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xubin Jing. Xubin Jing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 0
2 1
3 0
4 4
5 22
6 17
7 3
8 16
9 18
10 80
11
[Role of cyclooxygenase 2 and its inhibitor valdecoxib in liver fibrosis].
4
12 63
13 101
14 66
15
Mammalian target of rapamycin (mTOR) sigaling pathway involved in the inhibition of silence information regulator1 (Sirt1) on fat deposition of mice.
1
16 10
17
Curcumin induces apoptosis of esophageal cancer EC-109 cells by activating caspase-3.
1
18 25
19
[The role of reactive oxygen species in cisplatin-induced apoptosis of esophageal cancer cell line EC-109].
4
20 85

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026